Next Issue
Previous Issue
Due to scheduled maintaince work on one of the switches in our server center, our websites www.mdpi.com and susy.mdpi.com may experience short service dirsuptions of up to 5 minutes on 30 January 2015 00:00 PM EST time.

Table of Contents

Pharmaceuticals, Volume 3, Issue 4 (April 2010), Pages 782-1285

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-24

Research

Jump to: Review

p. 782-794
by  and
Pharmaceuticals 2010, 3(4), 782-794; doi:10.3390/ph3040782
Received: 18 January 2010 / Revised: 9 March 2010 / Accepted: 22 March 2010 / Published: 24 March 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (125 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Personalized Medicine)
p. 1045-1062
by , , ,  and
Pharmaceuticals 2010, 3(4), 1045-1062; doi:10.3390/ph3041045
Received: 22 December 2009 / Revised: 23 March 2010 / Accepted: 29 March 2010 / Published: 30 March 2010
Show/Hide Abstract | Cited by 6 | PDF Full-text (399 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
p. 1063-1069
by , , , , , , , , ,  and
Pharmaceuticals 2010, 3(4), 1063-1069; doi:10.3390/ph3041063
Received: 21 December 2009 / Revised: 5 January 2010 / Accepted: 29 March 2010 / Published: 31 March 2010
Show/Hide Abstract | Cited by 1 | PDF Full-text (207 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Asymmetric Synthesis and Medicinal Chemistry)
abstract graphic
p. 1070-1083
by  and
Pharmaceuticals 2010, 3(4), 1070-1083; doi:10.3390/ph3041070
Received: 17 December 2009 / Revised: 22 March 2010 / Accepted: 1 April 2010 / Published: 1 April 2010
Show/Hide Abstract | PDF Full-text (153 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antibiotics)
p. 1093-1107
by , , ,  and
Pharmaceuticals 2010, 3(4), 1093-1107; doi:10.3390/ph3041093
Received: 18 March 2010 / Accepted: 11 April 2010 / Published: 13 April 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (1216 KB) | HTML Full-text | XML Full-text | Supplementary Files
(This article belongs to the Special Issue Cell-penetrating Peptides)
abstract graphic
p. 1108-1121
by
Pharmaceuticals 2010, 3(4), 1108-1121; doi:10.3390/ph3041108
Received: 25 January 2010 / Revised: 19 March 2010 / Accepted: 1 April 2010 / Published: 14 April 2010
Show/Hide Abstract | PDF Full-text (244 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Interferons)
p. 1232-1240
by , ,  and
Pharmaceuticals 2010, 3(4), 1232-1240; doi:10.3390/ph3041232
Received: 11 February 2010 / Revised: 16 April 2010 / Accepted: 21 April 2010 / Published: 23 April 2010
Show/Hide Abstract | PDF Full-text (640 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
abstract graphic
p. 1279-1285
by , ,  and
Pharmaceuticals 2010, 3(4), 1279-1285; doi:10.3390/ph3041279
Received: 5 February 2010 / Revised: 14 April 2010 / Accepted: 19 April 2010 / Published: 26 April 2010
Show/Hide Abstract | PDF Full-text (42 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)

Review

Jump to: Research

p. 795-809
by , ,  and
Pharmaceuticals 2010, 3(4), 795-809; doi:10.3390/ph3040795
Received: 5 February 2010 / Revised: 24 March 2010 / Accepted: 24 March 2010 / Published: 25 March 2010
Show/Hide Abstract | Cited by 1 | PDF Full-text (1337 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Interferons)
abstract graphic
p. 810-838
by  and
Pharmaceuticals 2010, 3(4), 810-838; doi:10.3390/ph3040810
Received: 1 February 2010 / Revised: 15 March 2010 / Accepted: 19 March 2010 / Published: 25 March 2010
Show/Hide Abstract | Cited by 29 | PDF Full-text (638 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Tropical Medicine)
abstract graphic
p. 839-915
by
Pharmaceuticals 2010, 3(4), 839-915; doi:10.3390/ph3040839
Received: 31 December 2009 / Revised: 22 March 2010 / Accepted: 23 March 2010 / Published: 25 March 2010
Show/Hide Abstract | Cited by 32 | PDF Full-text (810 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Mitochondrial Drugs for Neurodegenerative Diseases)
p. 916-939
by ,  and
Pharmaceuticals 2010, 3(4), 916-939; doi:10.3390/ph3040916
Received: 5 January 2010 / Revised: 4 March 2010 / Accepted: 18 March 2010 / Published: 26 March 2010
Show/Hide Abstract | Cited by 1 | PDF Full-text (206 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antihypertensive Drugs)
p. 940-960
by
Pharmaceuticals 2010, 3(4), 940-960; doi:10.3390/ph3040940
Received: 22 December 2009 / Revised: 25 February 2010 / Accepted: 8 March 2010 / Published: 29 March 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (98 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antihypertensive Drugs)
abstract graphic
p. 961-993
by , ,  and
Pharmaceuticals 2010, 3(4), 961-993; doi:10.3390/ph3040961
Received: 22 December 2009 / Revised: 20 February 2010 / Accepted: 29 March 2010 / Published: 30 March 2010
Show/Hide Abstract | Cited by 55 | PDF Full-text (330 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Cell-penetrating Peptides)
p. 994-1015
by , , ,  and
Pharmaceuticals 2010, 3(4), 994-1015; doi:10.3390/ph3040994
Received: 2 March 2010 / Revised: 15 March 2010 / Accepted: 29 March 2010 / Published: 30 March 2010
Show/Hide Abstract | Cited by 23 | PDF Full-text (588 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Interferons)
p. 1016-1044
by , ,  and
Pharmaceuticals 2010, 3(4), 1016-1044; doi:10.3390/ph3041016
Received: 2 February 2010 / Revised: 15 March 2010 / Accepted: 26 March 2010 / Published: 30 March 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (1162 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antiasthmatic Drugs)
p. 1084-1092
by  and
Pharmaceuticals 2010, 3(4), 1084-1092; doi:10.3390/ph3041084
Received: 13 January 2010 / Revised: 1 April 2010 / Accepted: 9 April 2010 / Published: 12 April 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (155 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)
p. 1122-1138
by  and
Pharmaceuticals 2010, 3(4), 1122-1138; doi:10.3390/ph3041122
Received: 30 December 2009 / Revised: 12 March 2010 / Accepted: 9 April 2010 / Published: 15 April 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (241 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Personalized Medicine)
p. 1139-1161
by ,  and
Pharmaceuticals 2010, 3(4), 1139-1161; doi:10.3390/ph3041139
Received: 24 March 2010 / Revised: 8 April 2010 / Accepted: 14 April 2010 / Published: 19 April 2010
Show/Hide Abstract | Cited by 14 | PDF Full-text (439 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Antibiotics)
abstract graphic
p. 1162-1186
by  and
Pharmaceuticals 2010, 3(4), 1162-1186; doi:10.3390/ph3041162
Received: 9 March 2010 / Revised: 3 April 2010 / Accepted: 12 April 2010 / Published: 20 April 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (203 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Interferons)
p. 1187-1201
by ,  and
Pharmaceuticals 2010, 3(4), 1187-1201; doi:10.3390/ph3041187
Received: 16 March 2010 / Revised: 15 April 2010 / Accepted: 19 April 2010 / Published: 20 April 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (3648 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)
p. 1202-1224
by  and
Pharmaceuticals 2010, 3(4), 1202-1224; doi:10.3390/ph3041202
Received: 16 February 2010 / Revised: 25 March 2010 / Accepted: 29 March 2010 / Published: 20 April 2010
Show/Hide Abstract | Cited by 6 | PDF Full-text (312 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Targeted Therapy)
p. 1225-1231
by
Pharmaceuticals 2010, 3(4), 1225-1231; doi:10.3390/ph3041225
Received: 9 March 2010 / Revised: 21 April 2010 / Accepted: 22 April 2010 / Published: 22 April 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (169 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Protein Kinase Inhibitors)
p. 1241-1278
by , , ,  and
Pharmaceuticals 2010, 3(4), 1241-1278; doi:10.3390/ph3041241
Received: 14 February 2010 / Revised: 20 April 2010 / Accepted: 22 April 2010 / Published: 23 April 2010
Show/Hide Abstract | Cited by 6 | PDF Full-text (1390 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
abstract graphic
Select/unselect all
Displaying article 1-24
Select articles Export citation of selected articles as:
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert